Cardiff Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.About CRDF
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
CRDF Key Statistics
Stock Snapshot
Cardiff Oncology(CRDF) stock is priced at $1.02, giving the company a market capitalization of 79.29M. It carries a P/E multiple of -1.71.
As of 2026-10-14, Cardiff Oncology(CRDF) stock has fluctuated between $0.98 and $1.06. The current price stands at $1.02, placing the stock +4.0% above today's low and -3.8% off the high.
The Cardiff Oncology(CRDF)'s current trading volume is 157.52K, compared to an average daily volume of 450.84K.
In the last year, Cardiff Oncology(CRDF) shares hit a 52-week high of $3.31 and a 52-week low of $0.76.
In the last year, Cardiff Oncology(CRDF) shares hit a 52-week high of $3.31 and a 52-week low of $0.76.
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.